Cargando…
Are Cerebrospinal Fluid Biomarkers Useful in Predicting the Prognosis of Multiple Sclerosis Patients?
Multiple sclerosis (MS) is the prototypical inflammatory demyelinating disorder of the central nervous system (CNS). Although many advances have been made in the comprehension of its pathogenesis, the etiology is still unknown. The complexity of MS reflects in the extreme variability of the clinical...
Autores principales: | Gajofatto, Alberto, Bongianni, Matilde, Zanusso, Gianluigi, Benedetti, Maria Donata, Monaco, Salvatore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3233449/ https://www.ncbi.nlm.nih.gov/pubmed/22174643 http://dx.doi.org/10.3390/ijms12117960 |
Ejemplares similares
-
Cerebrospinal Fluid Markers in Sporadic Creutzfeldt-Jakob Disease
por: Zanusso, Gianluigi, et al.
Publicado: (2011) -
Clinical, MRI, and CSF Markers of Disability Progression in Multiple Sclerosis
por: Gajofatto, Alberto, et al.
Publicado: (2013) -
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis
por: Gajofatto, Alberto, et al.
Publicado: (2015) -
HCV-Related Nervous System Disorders
por: Monaco, Salvatore, et al.
Publicado: (2012) -
α‐Synuclein RT‐QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies
por: Bongianni, Matilde, et al.
Publicado: (2019)